HomeAI · summaries
Storia in 2 fonti
Pharmalittle: We're reading about a pancreatic cancer drug approval, a Trump deal with biotechs, and more
The FDA approved a life-extending treatment for advanced pancreatic cancer from Revolution Medicines that is the first to attack a genetic cause
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
statnews.com
Pharmalittle: We're reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more
President Trump’s pledge to make pricey weight loss drugs widely available for low-income Americans through Medicaid is not panning out
- ·
FDA approves new pancreatic cancer drug expected to usher in new era of treatment
The FDA has approved a life-extending treatment for advanced pancreatic cancer — the first such therapy to attack a genetic cause of the highly lethal malignancy.
